Production

Medreich facilities have received the seal of approval from leading global regulatory bodies such as -UK MHRA, Australia TGA, SA MCC, Health Canada, and French AFSSAP, GCC, PIC, regulatory bodies of various countries in the African continent and independent bodies like UNICEF and MSF.

Company was established in 1986, IOLCP is India's one of the leading generic pharmaceutical company, and is significant player in the Organic chemicals space. IOLCP has wide presence across various therapeutic categories like, Pain Management, Anti-diabetic, Anti hypertensive, Anti Convulsants, etc.

Adisan Laboratories came into existence in 1998 as a partnership firm which later on changed its constitution to a Private Limited Company. Initially Adisan started with certain bulk drugs and a catalyst required in manufacturing of foot and mouth disease vaccine. Then, after certain interval Adisan started manufacturing of liquid applications for external and veterinary use only. Presently Adisan is having facility to manufacture liquid applications for external and veterinary use , liquid disinfectants and powder disinfectants used poultry.

Bureau of Pharma Public Sector Undertakings of India, (Under the Dept. of Pharmaceuticals Govt. of India) is a nodal agency for implementing Pradhan Mantri Bhartiya Janaushadhi Pariyojana for Government of India. The noble objective of scheme is to making quality generic medicines available at affordable prices for all, through specialized outlets called Pradhan Mantri Bhartiya Janaushadhi Kendra (PMBJK). BPPI is procuring drugs from both private manufacturing unit and Central Public Sector Enterprises (CPSE), so requires technical experts who can undertake G.M.P. inspection both before selection of manufacturing unit and during the production of the drugs in the manufacturing unit. Expert is also required to do GLP inspection of drug testing labs.

Applications are invited from experienced persons for empanelment as Technical Expert for conducting GMP inspection of manufacturing unit and Drug testing labs. Interested candidates may send their applications along with resume to CEO, BPPI by speed post/courier by 12th May, 2017. Candidates who have applied against our earlier advertisement in Nov. 2016 need not to apply again. It may also be noted that this is not offer for regular full time employment.

Post : Technical Expert

Johnson & Johnson is the world’s most comprehensive and broadly based manufacturer of health care products.In India, Johnson & Johnson operates as a single legal entity and consists of the 3 strategic business units: Consumer Products, Pharmaceuticals and Medical Devices which are independently managed and report into their respective Global business segments.

Post : Team Leader-Production

Johnson & Johnson is the world’s most comprehensive and broadly based manufacturer of health care products.In India, Johnson & Johnson operates as a single legal entity and consists of the 3 strategic business units: Consumer Products, Pharmaceuticals and Medical Devices which are independently managed and report into their respective Global business segments.

Post : Team Leader Production

Par Pharmaceutical merging the business with Endo's Qualitest, thereby expanding the generics business to a top five industry leader.  Endo is highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, PA.

Post : PHARMACEUTICAL PROFESSIONALS

Biocon Limited is India's premier Biopharma enterprise focused on innovation to deliver affordable healthcare solutions to patients, partners and healthcare systems across the globe. We have fast evolved into an emerging global enterprise serving partners and customers in over 100 countries.

Post : Executive Sr. Executive Asst. Manager Deputy Manager

Cipla is one of the most respected pharmaceutical companies not just in India but across more than 170 countries. Our portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally. Cipla's turnover in FY13 was 1.5 billion USD.

Post : Officers/Associates